Read this issue’s cover story titled “Specialists navigate changing, challenging landscape of geographic atrophy management.” ...
If you're apprehensive about getting an intravitreal injection for age-related macular degeneration (AMD), you're not alone. Ophthalmologist Monika Fleckenstein, MD, explains the procedure, how it can ...
An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...
A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...
According to the report, the study examined 24 patients who were intravitreally injected four times in combination with four different types of anesthesia: topical proparacaine, topical tetracaine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results